WP
SBBP

WealthPLAN Partners’s Strongbridge Biopharma plc. SBBP Stock Holding History

WealthPLAN Partners’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$3.71K Buy
+740
New +$3.34K ﹤0.01% 772

Other funds holding SBBP

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
TAF
Tredje AP-fonden Se-111 91 Stockholm, Sweden $22.1B AUM 41.68% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
BJ
BlackRock Japan Tokyo, Japan $30.3B AUM 13.85% 1-Year Est. Return

WealthPLAN Partners's SBBP Position: Q3 2016 in Review

WealthPLAN Partners opened a new position in Strongbridge Biopharma plc. (SBBP) in Q3 2016: 740 shares worth $3.71K. The stake represents ﹤0.01% of the portfolio and ranks #772 among its holdings.

15 funds tracked by Wall St. Rank hold SBBP as of Q3 2016.

  • WealthPLAN Partners held 740 shares of Strongbridge Biopharma plc. worth $3.71K as of Q3 2016.
  • Strongbridge Biopharma plc. was a new WealthPLAN Partners position in Q3 2016.
  • Strongbridge Biopharma plc. made up ﹤0.01% of WealthPLAN Partners's portfolio in Q3 2016, its #772 holding.
  • 15 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q3 2016.

Based on WealthPLAN Partners's 13F filing for Q3 2016, filed 9 Dec 2016.